The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Scott D. Grosse

Division of Blood Disorders

National Center on Birth Defects and Developmental Disabilities

CDC, Atlanta

Georgia 30333

USA

[email]@cdc.gov

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Division of Blood Disorders, National Center on Birth Defects and Developmental Disabilities, CDC, Atlanta, Georgia 30333, USA. 2011
  • Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA 30333, USA. 2011
  • National Center on Birth Defects and Developmental Disabilities, USA. 2004 - 2010
  • Office of Planning, Evaluation, and Legislation, National Center For Environmental Health, USA. 2001

References

  1. Sickle cell disease in Africa: a neglected cause of early childhood mortality. Grosse, S.D., Odame, I., Atrash, H.K., Amendah, D.D., Piel, F.B., Williams, T.N. Am. J. Prev. Med (2011) [Pubmed]
  2. Prevention of intellectual disability through screening for congenital hypothyroidism: how much and at what level? Grosse, S.D., Van Vliet, G. Arch. Dis. Child. (2011) [Pubmed]
  3. Late-treated phenylketonuria and partial reversibility of intellectual impairment. Grosse, S.D. Child. Dev (2010) [Pubmed]
  4. Administrative data sets and health services research on hemoglobinopathies: a review of the literature. Grosse, S.D., Boulet, S.L., Amendah, D.D., Oyeku, S.O. Am. J. Prev. Med (2010) [Pubmed]
  5. Newborn screening for congenital cytomegalovirus: Options for hospital-based and public health programs. Grosse, S.D., Dollard, S., Ross, D.S., Cannon, M. J. Clin. Virol. (2009) [Pubmed]
  6. Disability and disability-adjusted life years: not the same. Grosse, S.D., Lollar, D.J., Campbell, V.A., Chamie, M. Public. Health. Rep (2009) [Pubmed]
  7. Economic productivity by age and sex: 2007 estimates for the United States. Grosse, S.D., Krueger, K.V., Mvundura, M. Med. Care (2009) [Pubmed]
  8. Economic evaluation of a neural tube defect recurrence-prevention program. Grosse, S.D., Ouyang, L., Collins, J.S., Green, D., Dean, J.H., Stevenson, R.E. Am. J. Prev. Med (2008) [Pubmed]
  9. Congenital cytomegalovirus (CMV) infection as a cause of permanent bilateral hearing loss: a quantitative assessment. Grosse, S.D., Ross, D.S., Dollard, S.C. J. Clin. Virol. (2008) [Pubmed]
  10. Long-term economic effect of early childhood nutrition. Grosse, S.D., Roy, K. Lancet (2008) [Pubmed]
  11. Lessons from cost-effectiveness research for United States public health policy. Grosse, S.D., Teutsch, S.M., Haddix, A.C. Annu. Rev. Public. Health (2007) [Pubmed]
  12. How many deaths can be prevented by newborn screening for congenital adrenal hyperplasia?. Grosse, S.D., Van Vliet, G. Horm. Res. (2007) [Pubmed]
  13. Newborn screening for inherited metabolic disease. Grosse, S.D., Dezateux, C. Lancet (2007) [Pubmed]
  14. Potential impact of newborn screening for cystic fibrosis on child survival: a systematic review and analysis. Grosse, S.D., Rosenfeld, M., Devine, O.J., Lai, H.J., Farrell, P.M. J. Pediatr. (2006) [Pubmed]
  15. From public health emergency to public health service: the implications of evolving criteria for newborn screening panels. Grosse, S.D., Boyle, C.A., Kenneson, A., Khoury, M.J., Wilfond, B.S. Pediatrics (2006) [Pubmed]
  16. Reevaluating the benefits of folic acid fortification in the United States: economic analysis, regulation, and public health. Grosse, S.D., Waitzman, N.J., Romano, P.S., Mulinare, J. Am. J. Public. Health (2005) [Pubmed]
  17. The cost effectiveness of universal versus selective newborn screening for sickle cell disease in the US and the UK: a critique. Grosse, S.D., Olney, R.S., Baily, M.A. Appl. Health. Econ. Health. Policy (2005) [Pubmed]
  18. Newborn screening for cystic fibrosis: evaluation of benefits and risks and recommendations for state newborn screening programs. Grosse, S.D., Boyle, C.A., Botkin, J.R., Comeau, A.M., Kharrazi, M., Rosenfeld, M., Wilfond, B.S. MMWR. Recomm. Rep (2004) [Pubmed]
  19. Assisting states in assessing newborn screening options. Grosse, S., Gwinn, M. Public. Health. Rep (2001) [Pubmed]
 
WikiGenes - Universities